Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient

In recent years, the evolution of treatments has made it possible to significantly improve the outcomes of patients with non-small cell lung cancer (NSCLC). In particular, while molecular targeted therapies are effective in specific patient sub-groups, immune checkpoint inhibitors (ICIs) have greatl...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancers (Basel)
Asıl Yazarlar: Rossi, Giovanni, Russo, Alessandro, Tagliamento, Marco, Tuzi, Alessandro, Nigro, Olga, Vallome, Giacomo, Sini, Claudio, Grassi, Massimiliano, Dal Bello, Maria Giovanna, Coco, Simona, Longo, Luca, Zullo, Lodovica, Tanda, Enrica Teresa, Dellepiane, Chiara, Pronzato, Paolo, Genova, Carlo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2020
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7281184/
https://ncbi.nlm.nih.gov/pubmed/32365882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12051125
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller